Sentence examples for tumour I from inspiring English sources

With increase in the size of the tumour (i.e., 2 3 cm) the effect of each parameter is not linear.

In this analysis, we compared the heterogeneity of the uptake of two tracers, [18F]FDG and AnxA5, in the same tumour, i.e. same day, same animal, same tumour, but different tracers of different size and retention mechanisms.

These results confirmed that invasive/aggressive tumour (i.e., able to form distant metastasis) affected distant 'non-tumour' lung tissue that behaved like T tissue regarding FADD release.

The first is the position and extent of gross tumour, i.e. what can be seen, palpated or imaged; this is known as the gross tumour volume (GTV).

Each tumour was represented by three cores on the TMAs allowing for a maximum of 12 observations per tumour (i.e., 3 cores × 2 observers × 2 scoring sessions).

Further imaging characterisation may suggest that the lesion is a benign cystic renal tumour, i.e. Bosniak I or II lesions.

Worth mentioning is that in the analyses per tumour, I-NHL, A-NHL and MM survivors who had been diagnosed more recently had higher perceived levels of information provision, which possibly indicates that information provision has improved with time.

As seen in Table 2, tumour 2B had the highest T/B ratio among the cold tumours, i.e. closest to unity, and tumours 9A and 9D had the lowest T/B ratios among the hot tumours, i.e. closest to unity.

The immunohistochemical characteristics of the engrafted tumours, i.e. overexpression of the proteins CD20, CD10, and Bcl2, were similar in both rituximab- and vehicle-treated mice.

This behaviour was also found in the muscles and in the tissues around the tumours (i.e. background) and had already been observed in the organs in our previous study [4].

When dividing stage I into tumour sizes 1 10 mm and 11 20 mm, the highest relative excess mortality was seen in the two youngest age groups with the smallest tumours, i.e. 1 10 mm.